Foreign establishment registration
This article was originally published in The Gray Sheet
Executive Summary
FDA reopens until Oct. 8 the comment period for its May 14 proposed rule requiring foreign firms whose products are imported or offered for import into the U.S. to register with FDA and identify a U.S. agent. In an Aug. 9 Federal Register notice, FDA says that the Canadian government requested the extension